Adherence to prescribing guidelines in the primary prevention of cardiovascular disease and in the management of patients with type 2 diabetes in Qatar

Mohammad Issam Mahmmoud Diab, Julienne Johnson

Research output: Contribution to journalConference Contribution

Abstract

Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes in Dublin, Ireland, 19–21 October 2011. The prevalence of diabetes mellitus (DM) in the UK increased in 2009 to 4%, of which type-2 diabetes accounts for 85–95% of all cases. In Qatar the prevalence of DM among the adult Qatari population in 2008 was 16.7%; around four times higher than the prevalence in the UK. The aim of the study was to design and to apply a medication assessment tool (MAT) to determine the level of adherence to internationally recognised guideline recommendations in type-2 diabetes management and in primary prevention of cardiovascular disease (CVD) among type-2 diabetes patients, to quantify any gaps in guideline implementation.
LanguageEnglish
Pages173-173
Number of pages1
JournalInternational Journal of Clinical Pharmacy
Volume34
Issue number1
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Qatar
Primary Prevention
Medical problems
Disease Management
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Guidelines
Diabetes Mellitus
Ireland
Population

Keywords

  • cardiovascular disease
  • type 2 diabetes
  • diabetes mellitus

Cite this

@article{fcec9b68924f4117befeeba0daaea8c2,
title = "Adherence to prescribing guidelines in the primary prevention of cardiovascular disease and in the management of patients with type 2 diabetes in Qatar",
abstract = "Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes in Dublin, Ireland, 19–21 October 2011. The prevalence of diabetes mellitus (DM) in the UK increased in 2009 to 4{\%}, of which type-2 diabetes accounts for 85–95{\%} of all cases. In Qatar the prevalence of DM among the adult Qatari population in 2008 was 16.7{\%}; around four times higher than the prevalence in the UK. The aim of the study was to design and to apply a medication assessment tool (MAT) to determine the level of adherence to internationally recognised guideline recommendations in type-2 diabetes management and in primary prevention of cardiovascular disease (CVD) among type-2 diabetes patients, to quantify any gaps in guideline implementation.",
keywords = "cardiovascular disease , type 2 diabetes , diabetes mellitus",
author = "Diab, {Mohammad Issam Mahmmoud} and Julienne Johnson",
note = "ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011",
year = "2012",
month = "2",
doi = "10.1007/s11096-011-9602-2",
language = "English",
volume = "34",
pages = "173--173",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7711",
number = "1",

}

Adherence to prescribing guidelines in the primary prevention of cardiovascular disease and in the management of patients with type 2 diabetes in Qatar. / Diab, Mohammad Issam Mahmmoud; Johnson, Julienne.

In: International Journal of Clinical Pharmacy, Vol. 34, No. 1, 02.2012, p. 173-173.

Research output: Contribution to journalConference Contribution

TY - JOUR

T1 - Adherence to prescribing guidelines in the primary prevention of cardiovascular disease and in the management of patients with type 2 diabetes in Qatar

AU - Diab, Mohammad Issam Mahmmoud

AU - Johnson, Julienne

N1 - ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011

PY - 2012/2

Y1 - 2012/2

N2 - Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes in Dublin, Ireland, 19–21 October 2011. The prevalence of diabetes mellitus (DM) in the UK increased in 2009 to 4%, of which type-2 diabetes accounts for 85–95% of all cases. In Qatar the prevalence of DM among the adult Qatari population in 2008 was 16.7%; around four times higher than the prevalence in the UK. The aim of the study was to design and to apply a medication assessment tool (MAT) to determine the level of adherence to internationally recognised guideline recommendations in type-2 diabetes management and in primary prevention of cardiovascular disease (CVD) among type-2 diabetes patients, to quantify any gaps in guideline implementation.

AB - Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes in Dublin, Ireland, 19–21 October 2011. The prevalence of diabetes mellitus (DM) in the UK increased in 2009 to 4%, of which type-2 diabetes accounts for 85–95% of all cases. In Qatar the prevalence of DM among the adult Qatari population in 2008 was 16.7%; around four times higher than the prevalence in the UK. The aim of the study was to design and to apply a medication assessment tool (MAT) to determine the level of adherence to internationally recognised guideline recommendations in type-2 diabetes management and in primary prevention of cardiovascular disease (CVD) among type-2 diabetes patients, to quantify any gaps in guideline implementation.

KW - cardiovascular disease

KW - type 2 diabetes

KW - diabetes mellitus

U2 - 10.1007/s11096-011-9602-2

DO - 10.1007/s11096-011-9602-2

M3 - Conference Contribution

VL - 34

SP - 173

EP - 173

JO - International Journal of Clinical Pharmacy

T2 - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7711

IS - 1

ER -